 |
rusalatide acetate |
|---|---|
| Trade Name | Chrysalin |
| Orphan Indication | Acute Radiation Syndrome Acute radiation syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-07 00:00:00 |
| Sponsor | Chrysalis BioTherapeutics, Inc.;2200 Market Street, Suite 609;Galveston, Texas, 77550 |
Learn more about: